Inhibition of TREM-1 alleviates neuroinflammation by modulating microglial polarization via SYK/p38MAPK signaling pathway after traumatic brain injury

CONCLUSIONS: These findings suggest that TREM-1 can be a potential clinical therapeutic target for alleviating neuroinflammation after TBI.PMID:38570153 | DOI:10.1016/j.brainres.2024.148907
Source: Brain Research - Category: Neurology Authors: Source Type: research